Articles appearing here come from many sources, but typically they are directly or indirectly based on recent WM research publications.
This is just a selection of our recent articles. If you can’t find what you’re looking for:
Another Clinical Trial Available in Canada: Nemtabrutinib
Nemtabrutinib (a.k.a. MK-1026 and ARQ 531) is a BTK inhibitor, [...]
Research Month: Interim Report from Dr. Hunter
Your donations to the WMFC are currently funding Dr. Zachary [...]
Help Promote Action on Rare Diseases!
As WMers, we often talk about the challenges of getting [...]
Paying for BTK Inhibitors in Canada
BTK Inhibitor drugs such as Ibrutinib, Zanubrutinib, etc, are very [...]
WMFC has a YouTube Channel!
We have a YouTube channel! https://www.youtube.com/channel/UCYDcXKrk4Nedjj_RIz1B_NQ will take you there. [...]
BRAWM Trial Update from Dr. Neil Berinstein
On Feb. 9th 2022, Dr. Neil Berinstein of the Sunnybrook [...]
Help Researchers Understand the Impact of Covid-19 on Canadian Blood Cancer Patients
A group of Canadian researchers is carrying on where [...]
2021 American Society of Hematology Conference: WM and Covid-19, and more
Every year, the American Society of Hematology (ASH) conference is [...]
Journal article: BTK Inhibitors for the Treatment of WM: A Canadian Perspective
This journal article by Dr. Frederic Larose and our frequent [...]
